Malin Johansson leads Life Science partnerships at Sleep Cycle, where she connects the company's sleep and respiratory intelligence with pharma, medtech, and digital health players building the next generation of prevention care and remote patient monitoring. She brings more than 15 years of experience spanning big pharma, medtech, and digital health startups, giving her a rare view of how clinical ambition, commercial reality, and technology actually come together. Her current work sits at the intersection of data, therapeutics, and digital health—integrating sleep and respiratory insights into partner ecosystems and shaping how life science companies think about digital engagement and prevention at scale. As a former Vice President of Global Digital Health Partnerships and Integrated Treatment Solutions at Novo Nordisk she established direct-to-consumer partnerships and initiatives and influenced the global digital health agenda delivered for brands like Ozempic and Wegovy. She brings a unique understanding of LoE impact and business preparation from working with brands like Humira, and she led the development and launch of several global patient support programmes to drive business impact and improve patient treatment outcomes. She is a regular voice in industry conversations about integrated care, scaling digital health and establishing new business models for pharma and medtech.